Newsroom
Sorted by: Latest
-
FONAR Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of FONAR Corporation - FONR
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of FONAR Corporation (NasdaqCM: FONR) to affiliates of Chief Executive Officer Timothy Damadian and certain executives and directors of the company. Under the terms of the proposed transaction, shareholders of FONAR will receive $19.00 per share of the Company's common stock, $19.00 per share of th...
-
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 7, 2026, at 4:30 p.m. ET to discuss its financial results for the fiscal 2026 second quarter ended March 31, 2026. Webcast and Conference Call Details Investors may access a live audio webcast on the Events and Presentations page under the Investors section of the Arrowhead website. A replay of the webcast will be available approximately two ho...
-
Semrush Unveils Brand Visibility Framework at Adobe Summit
BOSTON--(BUSINESS WIRE)--Semrush (NYSE: SEMR), the leading brand visibility platform, today unveiled a new strategic operating model for "Brand Visibility" during the Adobe Summit. The launch includes a two-part research report series: Brand Visibility Orchestration: How to execute on the Brand Visibility Operating model and Brand Visibility in the AI search era: A strategic framework for CMOs, designed to help marketing leaders transition from fragmented channel execution to a coordinated syst...
-
Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (“Spruce Biosciences”) (NASDAQ: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that it has commenced an underwritten public offering of shares of its common stock or pre-funded warrants to purchase shares of its common stock in lieu thereof. All of the securities are being offered by Spruce...
-
Definium Therapeutics Announces New Employee Inducement Grants
NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to five newly hired non-executive employees consisting of options to purchase an aggregate of 70,860 common shares of the Company (the "Options") with effective grant dates of April 6, 2026...
-
Lattice Collaborates with TI to Accelerate Edge AI for Robotics and Industrial Applications
HILLSBORO, Ore.--(BUSINESS WIRE)--Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that the company is collaborating with Texas Instruments (TI) to simplify sensor integration and to scale real-time edge AI systems. The combination of TI’s sensing technologies and the Lattice Holoscan Sensor Bridge solution, based on Lattice low power FPGA technology, will provide developers with a flexible hardware foundation for synchronized, low latency sensor data pip...
-
Green Brick Brands and Professionals Earn Eight Honors at 2026 McSAM Awards
PLANO, Texas--(BUSINESS WIRE)--Green Brick Partners, Inc. (NYSE: GRBK) is proud to announce that its homebuilding brands—CB JENI Homes, Normandy Homes, and Southgate Homes—earned eight honors at the 2026 McSAM Awards. Presented annually by the Dallas Builders Association, the McSAM Awards honor excellence in sales, marketing, and residential design across the Dallas Metroplex. This year’s recognition underscores Green Brick Partners’ continued commitment to excellence through differentiated bra...
-
Enhabit Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enhabit, Inc. - EHAB
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enhabit, Inc. (NYSE: EHAB) to Kinderhook Industries, LLC. Under the terms of the proposed transaction, shareholders of Enhabit will receive $13.80 per share in cash. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration...
-
CoastalSouth Bancshares, Inc. Reports Earnings for First Quarter 2026
ATLANTA--(BUSINESS WIRE)--CoastalSouth Bancshares, Inc. (NYSE: COSO) reports net income of $6.3 million, or $0.51 per diluted share, for the first quarter of 2026....
-
PPG investiert in Testanlage für strahlungshärtende Beschichtungen in Marly, Frankreich
MARLY, Frankreich--(BUSINESS WIRE)--PPG (NYSE: PPG) hat heute die Einrichtung einer hochmodernen Testanlage für strahlungshärtende Beschichtungen in seinem F&E-Kompetenzzentrum in Marly, Frankreich, bekannt gegeben. In dieser Anlage können verschiedene Härtungstechnologien getestet werden, darunter Infrarot (Infrared, IR), Ultraviolett (LED, Excimer- und Bogenlampen) sowie Elektronenstrahl (Electron Beam, EB). Durch diese Investition wird das Unternehmen in der Lage sein, die Produktionsbed...